| Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) M Banach, PE Penson, M Vrablik, M Bunc, K Dyrbus, J Fedacko, D Gaita, ... Pharmacological research 166, 105499, 2021 | 69 | 2021 |
| The impact of risk factors and comorbidities on the incidence of atrial fibrillation N Naser, M Dilic, A Durak, M Kulic, E Pepic, E Smajic, Z Kusljugic Materia socio-medica 29 (4), 231, 2017 | 65 | 2017 |
| Brain natriuretic peptide release in acute myocardial infarction A Durak-Nalbantić, A Džubur, M Dilić, Ž Pozderac, A Mujanović-Narančić, ... Bosnian journal of basic medical sciences 12 (3), 164, 2012 | 47 | 2012 |
| Serum level of tumor marker carbohydrate antigen-CA125 in heart failure A Durak-Nalbantic, N Resic, M Kulic, E Pecar, F Zvizdic, A Dzubur, M Dilic, ... Medical Archives 67 (4), 241, 2013 | 41 | 2013 |
| Blood pressure control in hypertensive patients, cardiovascular risk profile and the prevalence of masked uncontrolled hypertension (MUCH) N Naser, A Dzubur, A Durak, M Kulic, N Naser Medical Archives 70 (4), 274, 2016 | 35 | 2016 |
| ACS EuroPath Central & South European Countries Project. Optimal use of lipid-lowering therapy after acute coronary syndromes: a position paper endorsed by the International … M Banach, PE Penson, M Vrablik, M Bunc, K Dyrbus, J Fedacko, D Gaita, ... Pharmacol Res 166, 105499, 2021 | 33 | 2021 |
| Prognostic indicators of adverse renal outcome and death in acute kidney injury hospital survivors A Hamzić-Mehmedbašić, S Rašić, M Balavac, D Rebić, M Delić-Šarac, ... Journal of Renal Injury Prevention 5 (2), 61, 2016 | 24 | 2016 |
| The cumulative incidence of stroke, myocardial infarction, heart failure and sudden cardiac death in patients with atrial fibrillation N Naser, M Kulic, M Dilic, A Dzubur, A Durak, E Pepic, E Smajic, ... Medical Archives 71 (5), 316, 2017 | 23 | 2017 |
| Biphasic and monophasic pattern of brain natriuretic peptide release in acute myocardial infarction M Dilić, A Durak Nalbantić, A Arslanagić, J Huskić, S Brdjanović, M Kulić, ... Collegium antropologicum 35 (1), 155-159, 2011 | 21 | 2011 |
| Beta-blocker use in moderate and severe chronic obstructive pulmonary disease F Zvizdic, E Begic, A Mujakovic, E Hodzic, B Prnjavorac, O Bedak, ... Medical Archives 73 (2), 72, 2019 | 14 | 2019 |
| Renal function outcome prognosis in septic and non-septic acute kidney injury patients A Hamzic-Mehmedbasic, S Rasic, D Rebic, A Durak-Nalbantic, ... Medical Archives 69 (2), 77, 2015 | 13 | 2015 |
| The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure–HFrEF N Naser, A Durak–Nalbantic, N Sabanovic-Bajramovic, A Karic Medical Archives 77 (2), 105, 2023 | 8 | 2023 |
| Impact of different types of statins on clinical outcomes in patients hospitalized for ischemic heart failure F Zvizdić, A Godinjak, A Durak-Nalbantic, A Rama, A Iglica, ... Medical Archives 72 (6), 401, 2018 | 8 | 2018 |
| Serum aldosterone as predictor of progression of coronary heart disease in patients without signs of heart failure after acute myocardial infarction N Resic, A Durak-Nalbantic, A Dzubur, A Begic, E Begic Medical Archives 72 (6), 406, 2018 | 7 | 2018 |
| Predictors of hospitalization for heart failure decompensation in 18-months follow-up after index hospitalization for acute heart failure A Durak-Nalbantic, A Dzubur, N Nabil, A Hamzic-Mehmedbasic, F Zvizdic, ... Medical Archives 72 (4), 257, 2018 | 7 | 2018 |
| Central ACSE, South European Countries P. Optimal use o f lipid-lowering therapy after acute coronary syndromes: a position paper endorse d by the International Lipid Expert … M Banach, PE Penson, M Vrablik, M Bunc, K Dyrbus, J Fedacko, D Gaita, ... Pharm. Res 166, 105499, 2021 | 6 | 2021 |
| Effect of myocardial infarction on the occurrence of erectile dysfunction E Hodžić, A Durek, E Begić, NŠ Bajramović, A Durak-Nalbantić Med Glas (Zenica) 16 (1), 35-9, 2019 | 4 | 2019 |
| Significance of nitric oxyde saliva concentration of the patients with renal failure on hemodialysis M Vucijak-Grgurevic, F Zvizdic, A Durak-Nalbantic, E Jahic, N Resic, ... Materia Socio-medica 30 (4), 246, 2018 | 4 | 2018 |
| Optimal Choice of Pharmacological Therapy–Prevention of Stroke and Assessment of Bleeding Risk in Patients with Atrial Fibrillation E Hodzic, E Begic, S Zuhric, AD Nalbantic, Z Begic, I Masic International Journal of Preventive Medicine 10 (1), 85, 2019 | 3 | 2019 |
| Cardiomyopathies A Džubur, E Begić, NA Durak, B Aziri Galenika Medical Journal 2 (5), 23-30, 2023 | 2 | 2023 |
